Back to results
US 2012/0251548 A1Published application
Treatment of Dermatological Pathologies
AssigneeXbiotech, Inc.
InventorJohn Simard
Life of this patent
Estimating the term…
Abstract
Skin inflammation in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α.
Claims8
A method of reducing skin inflammation in a human subject, the method comprising the step of administering to the subject a pharmaceutical composition comprising a pharmaceutically acceptable carrier and an amount of an agent that selectively binds IL-1α effective to reduce skin inflammation in the subject.
Dependencies are inferred from the claim text.